Entities / Company
Avantor.
U.S. chemical company
- Reports this week
- 0
- Active events
- 2
- Connections
- 64
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
-
Avantor operates its first single-use plant in China.Some support3 reports
-
Both Avantor and Azenta are healthcare companies in life sciences, with Azenta operating in North America and global markets.Some support1 report
-
Citigroup and Royal Bank of Canada provided ratings and price targets for Avantor stock on September 15, 2026.Some support1 report
-
Avantor and Lasec have established a shared network of laboratory product suppliers.Some support3 reports
-
Avantor stock saw multiple financial activities on August 30, 2026, including 13F filings and analyst target price boosts from Morgan Stanley and Citigroup.Some support1 report
One to three months ago
-
Jefferies Financial Group upgraded Avantor's stock rating from underperform to hold.Some support1 report
-
Sotera Health Company, Agilent Technologies, and Avantor are companies operating in the research tools and consumables segment, supporting AI infrastructure.Some support2 reports
-
Royal Bank of Canada increased its stake in Avantor shares, leading to a required filing with the SEC.Some support1 report
-
Morgan Stanley analyst questioned Avantor management regarding the company's operations on August 5, 2026.Some support1 report
-
Avantor and Medpace operate in the life sciences tools & services segment.Some support1 report
-
Avantor and the Population Council expanded collaboration on an HIV prevention ring project, moving the product into regulatory review.Some support1 report
-
Tariffs benefit undervalued AI stocks, and a partnership expands global production footprint for a company.Well supported66 reports50 developments inside
-
Director Simon Dingemans purchased shares of Avantor, with the transaction filed with the Securities & Exchange Commission.Some support1 report
Gone quiet
No new reports in 90+ days-
Merck KGaA agreed to acquire Bio-Techne, while an analyst boosted the price target for Avantor stock.Some support1 report
-
Investigation into potential corporate wrongdoing involving Avantor and Bronstein, Gewirtz & Grossman, LLC.Some support1 report
-
A market analysis report from August 2025 identified key players in the Global Chemical Reagents Market, including Merck KGaA, Avantor, Honeywell, Becton Dickinson, Danaher, Bio-Rad, and Sigma-Aldrich.Some support1 report
-
Avantor is mentioned as a beneficiary of Trump tariffs.Some support2 reports
-
Bank of America and TD Cowen questioned Avantor analysts regarding Q2 sequential improvement and weakness in consumables.Speculative1 report
-
Avantor began using LinkedIn for corporate presence on June 27, 2025.Speculative1 report
-
Kadant, First Financial Bancorp, and Avantor were mentioned as high-quality stocks and businesses providing services in the U.S. since June 2025.Speculative1 report
-
Avantor's Europe segment outperformed other regions on August 5, 2025.Some support1 report
-
Avantor's CEO acknowledged high competitive intensity, while CFO emphasized margin pressures and Ligner prepared to take over as CEO.Some support5 reports
-
Engine Capital LP acquired an approximate 3% ownership stake in Avantor shares as of August 11, 2025.Some support1 report
-
Bank of America analysts questioned the sustainability of bioprocessing growth for Avantor on August 13, 2025.Some support1 report
-
Companies FSS, Avantor, BioPharma, and Enova detailed their diverse business profiles, including financial services and mission-critical products.Some support2 reports3 developments inside
-
Powell's dovish remarks on August 23, 2025, eased market concerns, affecting Avantor.Some support1 report
-
Gregory Summe was appointed as an Independent Director at Avantor.Some support1 report
-
Avantor, Moderna, and Bristol-Myers Squibb are companies operating in the healthcare industry, with Avantor supplying materials to biopharma.Some support3 reports
-
RBC Capital Markets lowered its price target for Avantor stock on September 4, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Avantor this week
News at the entities that move Avantor most-
Citigroup OperationalCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves Avantor
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Avantor
-
European Medicines Agency StructuralBoth the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Moves Avantor
-
Royal Bank of Canada TransactionalRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Avantor
-
Morgan Stanley OperationalFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves Avantor
-
Agilent Technologies OperationalKeysight Technologies was spun off from Hewlett-Packard on August 20, 2025.Moves Avantor
Connections
The 17 strongest of 64, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Todd Garner Structural
Avantor employs Todd Garner in the capacities of Executive Vice President and Chief Financial Officer.
-
Simon Dingemans Structural
Simon Dingemans serves as a director and purchased company shares of Avantor.
-
Citigroup Operational
Citigroup provided a rating and price target for Avantor stock.
-
Securities and Exchange Commission Structural
Avantor operates under the formal regulatory oversight of the U.S. Securities and Exchange Commission, evidenced by required 13F filings.
-
China Operational
Avantor is establishing a functional presence in China through the operation of a single-use plant.
-
SEC Structural
Avantor is subject to formal regulatory filings and oversight by the SEC.
-
Agilent Technologies Operational
Both companies actively compete in the research tools and consumables segment.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its investment stake and provided ratings for Avantor stock.
Show all 17 connections
-
Morgan Stanley Operational
Morgan Stanley conducts sell-side research on Avantor, including management interviews and price target adjustments.
-
European Medicines Agency Structural
Avantor's products are subject to regulatory review by the European Medicines Agency.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provided an analyst rating upgrade for Avantor.
-
Medpace Shared context
Both companies operate within the life sciences tools and services segment.
-
Apac Shared context
Avantor is expanding its portfolio availability across the geographic region of APAC.
-
Quantum-Si Incorporated Operational
Quantum-Si trained Avantor, which operates as a North American channel partner.
-
Manufacturers Life Insurance Company Transactional
Manufacturers Life Insurance Company acquired a new investment position in Avantor stock.
-
Barclays Mentioned together
Market analysts linked the two entities through coverage of Avantor's stock.
-
Lasec Shared context
The two companies operate within a shared network of laboratory product suppliers.
History
Events by the month they beganSeptember 2026
5 events- Avantor appointed Todd Garner as EVP and CFO.
- Avantor operates its first single-use plant in China.
- Both Avantor and Azenta are healthcare companies in life sciences, with Azenta operating in North America and global markets.
- Citigroup and Royal Bank of Canada provided ratings and price targets for Avantor stock on September 15, 2026.
- Avantor and Lasec have established a shared network of laboratory product suppliers.
August 2026
5 events- Avantor stock saw multiple financial activities on August 30, 2026, including 13F filings and analyst target price boosts from Morgan Stanley and Citigroup.
- Jefferies Financial Group upgraded Avantor's stock rating from underperform to hold.
- Sotera Health Company, Agilent Technologies, and Avantor are companies operating in the research tools and consumables segment, supporting AI infrastructure.
- Royal Bank of Canada increased its stake in Avantor shares, leading to a required filing with the SEC.
- Morgan Stanley analyst questioned Avantor management regarding the company's operations on August 5, 2026.
July 2026
3 events- Avantor and Medpace operate in the life sciences tools & services segment.
- Avantor and the Population Council expanded collaboration on an HIV prevention ring project, moving the product into regulatory review.
- Director Simon Dingemans purchased shares of Avantor, with the transaction filed with the Securities & Exchange Commission.
Show 1 earlier month
June 2026
18 events- Trump's oil and gas pledges benefit US stocks, specifically impacting Pfizer.
- Tariffs benefit undervalued AI stocks, and a partnership expands global production footprint for a company.
- Merck KGaA agreed to acquire Bio-Techne, while an analyst boosted the price target for Avantor stock.
- Investigation into potential corporate wrongdoing involving Avantor and Bronstein, Gewirtz & Grossman, LLC.
- A market analysis report from August 2025 identified key players in the Global Chemical Reagents Market, including Merck KGaA, Avantor, Honeywell, Becton Dickinson, Danaher, Bio-Rad, and Sigma-Aldrich.
- Avantor is mentioned as a beneficiary of Trump tariffs.
- Bank of America and TD Cowen questioned Avantor analysts regarding Q2 sequential improvement and weakness in consumables.
- Avantor began using LinkedIn for corporate presence on June 27, 2025.
- Kadant, First Financial Bancorp, and Avantor were mentioned as high-quality stocks and businesses providing services in the U.S. since June 2025.
- Avantor's Europe segment outperformed other regions on August 5, 2025.
- Avantor's CEO acknowledged high competitive intensity, while CFO emphasized margin pressures and Ligner prepared to take over as CEO.
- Engine Capital LP acquired an approximate 3% ownership stake in Avantor shares as of August 11, 2025.
- Bank of America analysts questioned the sustainability of bioprocessing growth for Avantor on August 13, 2025.
- Companies FSS, Avantor, BioPharma, and Enova detailed their diverse business profiles, including financial services and mission-critical products.
- Powell's dovish remarks on August 23, 2025, eased market concerns, affecting Avantor.
- Gregory Summe was appointed as an Independent Director at Avantor.
- Avantor, Moderna, and Bristol-Myers Squibb are companies operating in the healthcare industry, with Avantor supplying materials to biopharma.
- RBC Capital Markets lowered its price target for Avantor stock on September 4, 2025.